Glimepride 2 mg & Pioglitazone 30 mg (SR)

Send Inquiry

Request To Call Back

Glimepride 2 mg & Pioglitazone 30 mg (SR)

Get a Price/Quote

MOQ : 15-30 Boxes

Glimepride 2 mg & Pioglitazone 30 mg (SR) Specification

Life Span
24 months from manufacturing date

Packaging Type
Blister pack

Salt Composition
Glimepride and Pioglitazone

Pacakaging (Quantity Per Box)
100 tablets (10x10)

Brand Name
As per manufacturers brand

Dosage Form
Sustained Release Tablets

Indication
Non-insulin dependent diabetes mellitus (Type 2)

Drug Type
Specific Drug

Ingredients
Glimepride 2 mg + Pioglitazone 30 mg (SR)

Physical Form
Tablets

Function
Other

Recommended For
Management of Type 2 diabetes (NIDDM)

Dosage
As directed by physician, typically 1 tablet daily

Dosage Guidelines
Take with or after food, do not crush or chew

Suitable For
Adults

Quantity
10x10 tablets per box

Storage Instructions
Store in a cool, dry place away from sunlight

Batch Number
As per packaging

Route of Administration
Oral

Common Side Effects
Hypoglycemia, weight gain, edema

Shelf Packaging
Carton box/blister strip

Marketed By
Reputed Indian pharmaceutical companies

Regulatory Approval
DCGI approved formulation

Prescription Status
Prescription only

Contraindications
Not for use in Type 1 diabetes, diabetic ketoacidosis, severe liver dysfunction

Tablet Markings
May include batch or company code

Manufacturing Approval
WHO-GMP certified facility

Color
White

MRP per Strip
As per current market pricing

Shape
Round

Strength
Glimepride 2 mg, Pioglitazone 30 mg (SR)

Glimepride 2 mg & Pioglitazone 30 mg (SR) Trade Information

Minimum Order Quantity
15-30 Boxes

Payment Terms
Western Union, Paypal, Cash in Advance (CID), Cheque, Cash Advance (CA)

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Blister, 4*5*10

Main Domestic Market
All India

Certifications
WHO-GMP

About Glimepride 2 mg & Pioglitazone 30 mg (SR)

Experience peerless diabetes management with the new Glimepride 2 mg & Pioglitazone 30 mg (SR) tablets-crafted especially for adults with Type 2 diabetes. Marketed by reputed Indian pharmaceutical companies, this rarefied combination targets non-insulin dependent diabetes with lustrous efficacy. Manufactured in a WHO-GMP certified facility and DCGI approved, these white, round, sustained-release tablets offer customizable dosage under physician guidance. Get it now in secure blister packs (10x10) and streamline your diabetes care routine. Prescription only. Store in a cool, dry place for optimal shelf life.

Advanced Application and Competitive Advantage

Glimepride 2 mg & Pioglitazone 30 mg (SR) is specifically recommended for clinics, hospitals, and pharmacies catering to adult diabetic patients. It is used orally under prescription for sustained management of Type 2 diabetes. The combination's sustained release and peerless efficacy help in optimizing glycemic control while minimizing daily dosage frequency. Sourced from WHO-GMP certified exporters in India, it stands out due to its rarefied quality and reliable supply, offering clinicians a lustrous and competitively priced choice.

Efficient Dispatch and Secure Packaging Details

These tablets are dispatched promptly from India's major FOB ports. Each order is handed over in robust carton and blister strip packaging, ensuring integrity during transit. Orders benefit from quick dispatch timelines and organized logistics, minimizing any delay. Samples, if requested, are provided as per agreeable sample policy before bulk orders are confirmed, reflecting a customer-centric approach and commitment to global standards for exporter, manufacturer, and supplier partnerships.

FAQ's of Glimepride 2 mg & Pioglitazone 30 mg (SR):

Q: How should Glimepride 2 mg & Pioglitazone 30 mg (SR) be taken for optimal results?

A: This tablet is typically taken once daily with or after food, as directed by your physician. It is important not to crush or chew the tablet to ensure its sustained-release properties remain effective.

Q: What makes this combination peerless for Type 2 diabetes management?

A: This formulation combines the strengths of glimepride and pioglitazone for rarefied glycemic control, leveraging sustained release technology for consistent effectiveness and reduced pill frequency. It is WHO-GMP manufactured and DCGI approved, ensuring trusted quality.

Q: When should I avoid using Glimepride 2 mg & Pioglitazone 30 mg (SR)?

A: This medication is contraindicated in patients with Type 1 diabetes, diabetic ketoacidosis, or severe liver dysfunction. Always consult your healthcare provider before starting any new medication.

Q: Where can this product be exported or supplied from?

A: It is exported and supplied from reputed, WHO-GMP certified Indian pharmaceutical manufacturers with DCGI approval, ensuring compliance with international standards.

Q: What are the common side effects and how are they managed?

A: Common side effects may include hypoglycemia, weight gain, and edema. These can often be managed with dosage adjustment and regular monitoring under medical supervision.

Tell us about your requirement